SCHEMBL3096459

SCHEMBL3096459

O=C(OCCc1ccccc1)C1CCN(C(=O)O)CC1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.55
MEN1 O00255 1/20 0.55
KMT2A Q03164 1/20 0.55
NPC1 O15118 4/20 0.51
SMN1; SMN2 Q16637 3/20 0.51
RAB9A P51151 3/20 0.51
CYP2C19 P33261 1/20 0.49
ALDH1A1 P00352 3/20 0.48
GRIN2B Q13224 1/20 0.48
TSHR P16473 1/20 0.48
KDM4E B2RXH2 3/20 0.48
PKM P14618 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
CHRM5 P08912 3/20 0.47
CHRM1 P11229 3/20 0.47
CHRM3 P20309 3/20 0.47
CHRM2 P08172 2/20 0.47
CHRM4 P08173 2/20 0.47
HSD17B10 Q99714 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4034005 0.89 SMN1; SMN2 (0.53) POLBMEN1KMT2ANPC1SMN1; SMN2
SCHEMBL3504514 0.86 HCAR2 (0.51) POLBMEN1KMT2ANPC1SMN1; SMN2
SCHEMBL205217 0.85 SMN1; SMN2 (0.65) POLBMEN1KMT2ANPC1SMN1; SMN2
SCHEMBL27812150 0.83 ATM (0.51) NPC1SMN1; SMN2RAB9ACYP2C19ALDH1A1
SCHEMBL3503104 0.82 FKBP1A (0.54) POLBSMN1; SMN2CYP2C19ALDH1A1L3MBTL1
SCHEMBL27694957 0.79 AKR1B10 (0.47) MEN1KMT2ANPC1SMN1; SMN2RAB9A
SCHEMBL28514277 0.77 LMNA (0.60) POLBMEN1KMT2ANPC1SMN1; SMN2
SCHEMBL6642777 0.77 SMN1; SMN2 (0.62) POLBMEN1KMT2ANPC1SMN1; SMN2
SCHEMBL1222959 0.77 POLB (0.71) POLBMEN1KMT2ANPC1SMN1; SMN2
SCHEMBL1588471 0.76 HCAR2 (0.47) NPC1SMN1; SMN2RAB9AALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8357717-B2 Spiro group-containing amide compounds having bradykinin 1 receptor (B1R) activity GRUENENTHAL GMBH (DE) 2013-01-22 US disclosed
US-20100234340-A1 Substituted Spiroamide Compounds GRUENENTHAL GMBH (DE) 2010-09-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100234340-A1 Substituted Spiroamide Compounds BDKRB1, BDKRB2, AVPR1B POLB 3022/4885MEN1 1130/4885KMT2A 2897/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.